Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Generation Bio Co. (GBIO)

Generation Bio Co. (GBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,913
  • Shares Outstanding, K 6,738
  • Annual Sales, $ 19,890 K
  • Annual Income, $ -131,670 K
  • EBIT $ -70 M
  • EBITDA $ -65 M
  • 60-Month Beta 1.96
  • Price/Sales 1.77
  • Price/Cash Flow N/A
  • Price/Book 0.70

Options Overview Details

View History
  • Implied Volatility 0.00% (unch)
  • Historical Volatility 45.17%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 905.68% on 03/11/25
  • IV Low 0.00% on 12/02/25
  • Expected Move (DTE 41) 0.04 (0.81%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,290
  • Open Int (30-Day) 1,290
  • Expected Range 5.18 to 5.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -1.08
  • Number of Estimates 1
  • High Estimate -1.08
  • Low Estimate -1.08
  • Prior Year -3.20
  • Growth Rate Est. (year over year) +66.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.91 +8.55%
on 11/21/25
5.89 -9.51%
on 11/13/25
+0.14 (+2.70%)
since 11/05/25
3-Month
4.91 +8.55%
on 11/21/25
6.92 -22.98%
on 10/16/25
-0.66 (-11.02%)
since 09/05/25
52-Week
3.00 +77.43%
on 06/27/25
13.80 -61.38%
on 12/09/24
-7.47 (-58.36%)
since 12/05/24

Most Recent Stories

More News
Generation Bio Announces Third Quarter 2025 Financial Results

CAMBRIDGE, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co . (Nasdaq: GBIO), a biotechnology company, today reported third quarter financial results. Third Quarter 2025 Financial Results...

GBIO : 5.33 (+2.11%)
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Dr. Jeffrey Jonas...

GBIO : 5.33 (+2.11%)
CMPS : 5.82 (+2.46%)
Generation Bio Announces CEO Transition

• Geoff McDonough, MD to step down as CEO & President and become Chair of the Company’s Board of Directors • Current Chief Legal Officer Yalonda Howze, JD named Interim CEO & President ...

GBIO : 5.33 (+2.11%)
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results

• New data confirm highly selective profile of cell-targeted lipid nanoparticle (ctLNP) and first-ever siRNA delivery to T cells in non-human primates • Lead siRNA candidates show potent knockdown...

GBIO : 5.33 (+2.11%)
Generation Bio Announces 1-for-10 Reverse Stock Split

CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases,...

GBIO : 5.33 (+2.11%)
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

GBIO : 5.33 (+2.11%)
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference

GBIO : 5.33 (+2.11%)
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results

GBIO : 5.33 (+2.11%)
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference

GBIO : 5.33 (+2.11%)
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

GBIO : 5.33 (+2.11%)

Business Summary

Generation Bio Co. is a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases. The company is developing distinct and complementary platforms a potent, highly selective cell-targeted lipid nanoparticle delivery system and a novel immune-quiet DNA cargo...

See More

Key Turning Points

3rd Resistance Point 5.71
2nd Resistance Point 5.57
1st Resistance Point 5.45
Last Price 5.33
1st Support Level 5.19
2nd Support Level 5.05
3rd Support Level 4.93

See More

52-Week High 13.80
Fibonacci 61.8% 9.68
Fibonacci 50% 8.40
Fibonacci 38.2% 7.13
Last Price 5.33
52-Week Low 3.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar